Ching Ho Chang
Director/Board Member presso UNITED BIOPHARMA INC
Profilo
Ching Ho Chang is currently an Independent Director at Evergreen International Storage & Transport Corp., a Member-Supervisory Board at H&H Venture Capital Investment Corp., TaiAn Technologies Corp., United Biomedical, Inc. Asia, and United BioPharma, Inc. He previously served as an Independent Director at Tang Eng Iron Works Co. Ltd., an Independent Director at TaiwanJ Pharmaceuticals Co., Ltd., and a Member-Supervisory Board at UBI Pharma Inc. Chang holds a graduate degree from Washington State University and an undergraduate degree from National Cheng Kung University.
Posizioni attive di Ching Ho Chang
Società | Posizione | Inizio |
---|---|---|
UNITED BIOPHARMA INC | Director/Board Member | 30/09/2013 |
EVERGREEN INTERNATIONAL STORAGE & TRANSPORT CORPORATION | Director/Board Member | 12/06/2014 |
TaiAn Technologies Corp.
TaiAn Technologies Corp. Investment ManagersFinance TaiAn Technologies Corp. operates as a technology advisory company. It specializes in commercializing intellectual properties in the life sciences. The firm identifies and transfers promising technologies from the portfolio companies of the fund into Taiwan and to help catapult the local healthcare related industries up to the global competitive levels. The company was founded in February 2002 and is headquartered in Taipei, Taiwan. | Director/Board Member | - |
United Biomedical, Inc. Asia
United Biomedical, Inc. Asia BiotechnologyHealth Technology Part of United Biomedical, Inc., United Biomedical, Inc. Asia is a private company based in Taipei, Taiwan that specializes in the research, development, manufacturing, and sales of innovative biotech medical products, particularly vaccines based on synthetic peptides for humans and animals. The Taiwanese company utilizes the core technology of its parent company, UBI, called "UBITh® functional antigenicology," to develop these innovative vaccines. The company offers a range of products, including an anti-IL-6 human vaccine and a COVID-19 vaccine called UB-612. | Director/Board Member | - |
H&H Venture Capital Investment Corp. | Director/Board Member | - |
Precedenti posizioni note di Ching Ho Chang
Società | Posizione | Fine |
---|---|---|
UBI PHARMA INC. | Director/Board Member | - |
TANG ENG IRON WORKS CO., LTD. | Director/Board Member | - |
TAIWANJ PHARMACEUTICALS CO., LTD. | Director/Board Member | - |
Formazione di Ching Ho Chang
Washington State University | Graduate Degree |
National Cheng Kung University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
EVERGREEN INTERNATIONAL STORAGE & TRANSPORT CORPORATION | Transportation |
TANG ENG IRON WORKS CO., LTD. | Non-Energy Minerals |
TAIWANJ PHARMACEUTICALS CO., LTD. | Health Technology |
UBI PHARMA INC. | Health Technology |
Aziende private | 4 |
---|---|
H&H Venture Capital Investment Corp. | |
TaiAn Technologies Corp.
TaiAn Technologies Corp. Investment ManagersFinance TaiAn Technologies Corp. operates as a technology advisory company. It specializes in commercializing intellectual properties in the life sciences. The firm identifies and transfers promising technologies from the portfolio companies of the fund into Taiwan and to help catapult the local healthcare related industries up to the global competitive levels. The company was founded in February 2002 and is headquartered in Taipei, Taiwan. | Finance |
United Biomedical, Inc. Asia
United Biomedical, Inc. Asia BiotechnologyHealth Technology Part of United Biomedical, Inc., United Biomedical, Inc. Asia is a private company based in Taipei, Taiwan that specializes in the research, development, manufacturing, and sales of innovative biotech medical products, particularly vaccines based on synthetic peptides for humans and animals. The Taiwanese company utilizes the core technology of its parent company, UBI, called "UBITh® functional antigenicology," to develop these innovative vaccines. The company offers a range of products, including an anti-IL-6 human vaccine and a COVID-19 vaccine called UB-612. | Health Technology |
United BioPharma, Inc.
United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
- Borsa valori
- Insiders
- Ching Ho Chang